Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020.
Jeffery-Smith A, Iyanger N, Williams SV, Chow JY, Aiano F, Hoschler K, Lackenby A, Ellis J, Platt S, Miah S, Brown K, Amirthalingam G, Patel M, Ramsay ME, Gopal R, Charlett A, Ladhani SN, Zambon M. Jeffery-Smith A, et al. Among authors: hoschler k. Euro Surveill. 2021 Feb;26(5):2100092. doi: 10.2807/1560-7917.ES.2021.26.5.2100092. Euro Surveill. 2021. PMID: 33541486 Free PMC article.
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.
Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA. Temperton NJ, et al. Among authors: hoschler k. Influenza Other Respir Viruses. 2007 May;1(3):105-12. doi: 10.1111/j.1750-2659.2007.00016.x. Influenza Other Respir Viruses. 2007. PMID: 19453415 Free PMC article.
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.
Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina M, Nguyen-Van-Tam JS, Read RC, Warren FC, Zambon M. Nicholson KG, et al. Among authors: hoschler k. Health Technol Assess. 2010 Dec;14(55):193-334. doi: 10.3310/hta14550-04. Health Technol Assess. 2010. PMID: 21208550 Free article. Clinical Trial.
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children.
Okike IO, Yung C, Ladhani S, Oeser C, Bennett A, Doerholt K, Storey S, Donaghy S, Butter N, Hoschler K, Sheasby L, Heath PT, Miller E. Okike IO, et al. Among authors: hoschler k. Vaccine. 2011 Sep 2;29(38):6636-40. doi: 10.1016/j.vaccine.2011.06.103. Epub 2011 Jul 13. Vaccine. 2011. PMID: 21742005
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.
Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, Hoschler K, Brown K, Galiano M, Myers R, Pebody RG, Green HK, Boddington NL, Gopal R, Price N, Newsholme W, Drosten C, Fouchier RA, Zambon M. Bermingham A, et al. Among authors: hoschler k. Euro Surveill. 2012 Oct 4;17(40):20290. Euro Surveill. 2012. PMID: 23078800 Free article.
120 results